CD34 and neoplasm: Additionally, this group exhibited significantly lower expression of Ki67 and CD34 compared to other groups, suggesting that the DCM@OPR + L group could effectively suppress tumor growth (Fig. 5f, Supplementary Figs. 36, 37).